The comet assay in clinical practice

Acta Oncologica

Volumn 38, Issue 7, 1999, Pages 839-844

  Olive, Peggy L ^a   Durand, Ralph E ^a   Jackson, Stewart M ^a   Le Riche, Jean C ^a   Luo, Chenmei ^a   Ma, Roy ^a   McLaren, Duncan B ^a   Aquino Parsons, Christina ^a   Thomson, Thomas A ^a   Trotter, Theresa ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; CLINICAL PRACTICE; DIAGNOSTIC VALUE; DNA DAMAGE; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; HYPOXIC CELL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIOSENSITIVITY;

ANIMALS; BIOPSY, NEEDLE; CELL HYPOXIA; COMET ASSAY; DNA DAMAGE; ELECTROPHORESIS; HUMANS; MICE; MICE, INBRED C3H; NEOPLASMS;

EID: 0032756195     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699432527     Document Type: Article

References (29)

1. Ostling O, Johanson KJ. Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem Biophys Res Commun 1984; 123: 291-8.
2. Fairbairn DW, Olive PL, O'Neill KL. The comet assay: a comprehensive review. Mutât Res 1995; 339: 37-59.
3. McKelvey-Martin VM, Green MHL, Schmezer P, Pool-Zobel BL, DeMeo MP, Collins A. The single cell gel electrophoresis assay (Comet assay): a European review Mutât Res 1993; 288: 47-63.
4. Schmezer P. The Comet Assay. Special issue of Mutât Res 1997; vol 375, no 2. Amsterdam: Elsevier.
5. Olive PL, Johnston PJ, Banath JP, Durand RE. The comet assay: a new method to examine heterogeneity associated with solid tumours. Nature Med 1998; 4: 103-5.
6. Olive PL, Durand RE, LeRiche J, Olivotto I, Jackson SM. Gel electrophoresis of individual cells to quantify hypoxic fraction in human breast cancers. Cancer Res 1993; 53: 733-6.
7. Olive PL, Trotter T, Banath JP, Jackson SM, LeRiche J. Heterogeneity in human tumour hypoxic fraction measured using the comet assay. Br J Cancer 1996; 74: 191S-5S.
8. McLaren DB, Pickles T, Thomson T, Olive PL. Impact of nicotinamide on human tumour hypoxic fraction measured using the comet assay. Radiother & Oncol 1997; 45: 175-82.
9. Olive PL, Banath JP. Growth fraction measured using the comet assay. Cell Prolif 1992; 25: 447-57.
10. Olive PL, LeRiche J, Jackson SM. Growth fraction of human tumours: assays and complications. Semin Radiât Oncol 1993; 7: 90-8.
11. Tice RR, Strauss GH, Peters WP. High-dose combination alkylating agents with autologous bone-marrow support in patients with breast cancer: preliminary assessment of DNA damage in individual peripheral blood lymphocytes using the single cell gel electrophoresis assay. Mutât Res 1992; 271: 101-3.
12. Vaghef H, Nygren P, Edling C, Bergh J, Hellman B. Alkaline single-cell gel electrophoresis and human biomonitoring for genotoxicity: a pilot study on breast cancer patients undergoing chemotherapy using cyclophosphamide. Mutât Res 1997; 395: 127-38.
13. Hartmann A, Herkomer K, Gluck M, Speit G. DNA damage effect of cyclophosphamide on human blood cells in vivo and in vitro studied with the single-cell gel test (comet assay). Environ & Molec Mutagen 1995; 25: 180-7.
14. Olive PL, Jackson SM, Durand RE. Predicting tumour response to radiotherapy using the comet assay. In: Paliwal BR, Kinsella TJ, Herbert D, Fowler J, eds. Proceedings of the 4th International Conference on Time, Dose and Fractionation in Radiation Oncology. Woodbury (NY): The American Institute of Physics, 1993: 65-76.
15. Olive PL, Horsman M, Grau C, Overgaard J. Detection of hypoxic cells in a C3H mouse mammary carcinoma using the comet assay. Br J Cancer 1997; 76: 694-9.
16. Olive PL, Banath JP, Durand RE. Heterogeneity in radiationinduced DNA damage and repair in tumour and normal cells measured using the 'comet' assay. Radiât Res 1990; 122: 69-72.
17. Strauss GHS, Peters WP, Everson RB. Measuring DNA damage in individual cells of heterogeneous mixtures: a novel application of an immunological typing technique. Mutât Res 1994; 304: 211-6.
18. Aquino-Parsons C, Luo C, Vikse CM, Olive PL. Comparison between the comet assay and the oxygen microelectrode for measurement of tumour hypoxia. Radiother & Oncol, in press.
19. Utrasun RC, Parliament MB, McEwan AJ, et al. Measurement of hypoxia in human tumours by non-invasive SPECT imaging of iodoazomycin arabinoside. Br J Cancer 1996; 74: S209-I2.
20. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996; 56:4509-15.
21. Rasey JS, Koh W, Evans ML, et al. Quantifying regional hypoxia in human tumors with positron emission tomography of 18F-fluoromisonidazole: A pretherapy study of 37 patients. Int J Radiât Oncol Biol Phys 1996; 36: 417-28.
22. Banath JP, Wallace SS, Thompson J, Olive, PL. Base damage detected using the alkaline comet assay: oxygen enhancement ratio and influence of single-strand breaks. Radiât Res, in press.
23. Olive PL, Banath JP. Multicell spheroid response to drugs predicted with the comet assay. Cancer Res 1997; 57: 552833.
24. Olive PL, Vikse CM, Banath JP. Use of the comet assay to identify cells sensitive to tirapazamine in multicell spheroids and tumours in mice. Cancer Res 1996; 56: 4460-3.
25. Huang P, Olive PL, Durand RE. Use of the comet assay for assessment of drug resistance and its modulation in vivo. Br J Cancer 1998; 77: 412-6.
26. Olive PL. Use of the comet assay to detect hypoxic cells in murine tumours and normal tissues exposed to bioreductive drugs. Acta Oncol 1995; 34: 301-5.
27. McCurdy D, Tail LQ, Prias S, Wang Z. Delayed repair of DNA damage by ionizing radiation in cells from patients with juvenile systemic lupus erythematosus and rheumatoid arthritis. Radiât Res 1997; 147: 48-54.
28. Banath JP, Fushiki M, Olive PL. Rejoining of DNA single-and double-strand breaks in human white blood cells exposed to ionizing radiation. Int J Radiât Oncol 1998; 73: 649-60.
29. Alapete C, Benoît A, Moustacchi E, Sarasin A. The comet assay as a repair test for prenatal diagnosis of Xeroderma pigmentosum and trichothiodystrophy. J Invest Dermatol 1997; 108: 154-9.